Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of $149.04 billion. The enterprise value is $207.03 billion.

Market Cap	149.04B
Enterprise Value	207.03B

Important Dates

The last earnings date was Tuesday, February 4, 2025, before market open.

Earnings Date	Feb 4, 2025
Ex-Dividend Date	Jan 24, 2025

Share Statistics

Pfizer has 5.67 billion shares outstanding. The number of shares has decreased by -0.16% in one year.

Current Share Class	5.67B
Shares Outstanding	5.67B
Shares Change (YoY)	-0.16%
Shares Change (QoQ)	-0.04%
Owned by Insiders (%)	0.03%
Owned by Institutions (%)	66.96%
Float	5.66B

Valuation Ratios

The trailing PE ratio is 18.65 and the forward PE ratio is 8.90. Pfizer's PEG ratio is 3.47.

PE Ratio	18.65
Forward PE	8.90
PS Ratio	2.34
Forward PS	2.34
PB Ratio	1.61
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	3.47

Financial Ratio History

Enterprise Valuation

EV / Earnings	25.78
EV / Sales	3.25
EV / EBITDA	8.90
EV / EBIT	12.68
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.73
Debt / EBITDA	2.92
Debt / FCF	n/a
Interest Coverage	5.28

Financial Efficiency

Return on equity (ROE) is 8.85% and return on invested capital (ROIC) is 6.28%.

Return on Equity (ROE)	8.85%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	6.28%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	$723,034
Profits Per Employee	$91,261
Employee Count	88,000
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-28.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -4.68% in the last 52 weeks. The beta is 0.57, so Pfizer's price volatility has been lower than the market average.

Beta (5Y)	0.57
52-Week Price Change	-4.68%
50-Day Moving Average	26.22
200-Day Moving Average	27.86
Relative Strength Index (RSI)	53.46
Average Volume (20 Days)	40,917,384

Short Selling Information

The latest short interest is 73.57 million, so 1.30% of the outstanding shares have been sold short.

Short Interest	73.57M
Short Previous Month	75.71M
Short % of Shares Out	1.30%
Short % of Float	1.30%
Short Ratio (days to cover)	2.07

Income Statement

In the last 12 months, Pfizer had revenue of $63.63 billion and earned $8.03 billion in profits. Earnings per share was $1.41.

Revenue	63.63B
Gross Profit	47.21B
Operating Income	16.33B
Pretax Income	-4.20B
Net Income	8.03B
EBITDA	23.27B
EBIT	16.33B
Earnings Per Share (EPS)	$1.41

Full Income Statement

Balance Sheet

The company has $9.95 billion in cash and $67.95 billion in debt, giving a net cash position of -$57.99 billion or -$10.23 per share.

Cash & Cash Equivalents	9.95B
Total Debt	67.95B
Net Cash	-57.99B
Net Cash Per Share	-$10.23
Equity (Book Value)	92.56B
Book Value Per Share	16.29
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 74.19%, with operating and profit margins of 25.66% and 12.62%.

Gross Margin	74.19%
Operating Margin	25.66%
Pretax Margin	12.61%
Profit Margin	12.62%
EBITDA Margin	36.57%
EBIT Margin	25.66%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of $1.72, which amounts to a dividend yield of 6.54%.

Dividend Per Share	$1.72
Dividend Yield	6.54%
Dividend Growth (YoY)	2.42%
Years of Dividend Growth	10
Payout Ratio	121.82%
Buyback Yield	0.16%
Shareholder Yield	6.70%
Earnings Yield	5.39%
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for Pfizer is $31.92, which is 21.37% higher than the current price. The consensus rating is "Buy".

Price Target	$31.92
Price Target Difference	21.37%
Analyst Consensus	Buy
Analyst Count	14
Revenue Growth Forecast (5Y)	-1.77%
EPS Growth Forecast (5Y)	14.18%

Stock Forecasts

Stock Splits

The last stock split was on July 1, 1999. It was a forward split with a ratio of 3:1.

Last Split Date	Jul 1, 1999
Split Type	Forward
Split Ratio	3:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2